HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jessie R Groothuis Selected Research

Palivizumab

2/2011Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
8/2010The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children.
6/2008Use of Palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis.
7/2007Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.
1/2003Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection.
9/2002Development and use of palivizumab (Synagis): a passive immunoprophylactic agent for RSV.
6/2002Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jessie R Groothuis Research Topics

Disease

3Respiratory Syncytial Virus Infections
07/2006 - 06/2002
2Infections
02/2011 - 02/2011
2Lung Diseases (Lung Disease)
02/2011 - 07/2007
2Respiratory Sounds (Crackle)
08/2010 - 07/2007
1Congenital Heart Defects (Congenital Heart Defect)
02/2011
1Respiratory Tract Diseases (Respiratory Tract Disease)
02/2011
1Thrombocytopenia (Thrombopenia)
12/2010
1Neutropenia
12/2010
1Food Hypersensitivity (Food Allergy)
08/2010
1Asthma (Bronchial Asthma)
08/2010
1Disease Susceptibility (Diathesis)
08/2010
1Cystic Fibrosis (Mucoviscidosis)
06/2008
1Body Odor
07/2003
1Halitosis
07/2003
1Respiratory Tract Infections (Respiratory Tract Infection)
09/2002
1Communicable Diseases (Infectious Diseases)
09/2002
1Injection Site Reaction
06/2002

Drug/Important Bio-Agent (IBA)

7PalivizumabFDA Link
02/2011 - 06/2002
4Monoclonal AntibodiesIBA
02/2011 - 06/2002
1Neutralizing AntibodiesIBA
02/2011
1Formaldehyde (Formol)FDA Link
02/2011
1Immunoglobulin G (IgG)IBA
02/2011
1VaccinesIBA
02/2011
1SuspensionsIBA
12/2010
1Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2003
1Capsules (Microcapsules)IBA
07/2003

Therapy/Procedure

1Critical Care (Surgical Intensive Care)
07/2006